You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Unresectable Liver Tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Liver Diseases, Liver Cancer, Liver Metastases Trial in Murcia (Liver Transplantation)

Not yet recruiting
  • Liver Diseases
  • +27 more
  • Liver Transplantation
  • Murcia, Spain
    Felipe Alconchel
Feb 24, 2022

Hepatocellular Carcinoma, Liver Metastases, Cholangiocarcinoma Trial in United States (STP705)

Active, not recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

Colorectal Tumors, Tumor Metastasis, Liver Tumors Trial in Shanghai (chemo ± targeted therapy)

Completed
  • Colorectal Neoplasms
  • +3 more
  • chemotherapy ± targeted therapy
  • Shanghai, Shanghai, China
    Zhongshan hospital, Fudan university
Jun 12, 2022

Gastrointestinal Tumors Trial in Nanjing, Wuxi, Shanghai (Anlotinib + Oxaliplatin + Capecitabine, Anlotinib + Cisplatin +

Recruiting
  • Gastrointestinal Tumors
  • Anlotinib + Oxaliplatin + Capecitabine
  • +2 more
  • Nanjing, Jiangsu, China
  • +6 more
Feb 21, 2022

Liver Cancer Trial in Guangzhou (Irreversible electroporation (IRE))

Completed
  • Liver Cancer
  • Irreversible electroporation (IRE)
  • Guangzhou, Guangdong, China
    Fuda Cancer Hospital
Sep 1, 2021

Colon Cancer Liver Metastases Trial (sequential adult left lateral lobe liver transplantation (SALT))

Not yet recruiting
  • Colon Cancer Liver Metastases
  • sequential adult left lateral lobe liver transplantation (SALT)
  • (no location specified)
Oct 3, 2023

Liver Transplant Disorder, Hepatic Cancer Trial (assisted liver transplantation combined with two-stage hepatectomy)

Not yet recruiting
  • Liver Transplant Disorder
  • Hepatic Cancer
  • assisted liver transplantation combined with two-stage hepatectomy
  • (no location specified)
Mar 6, 2023

Unresectable Colorectal Liver Metastases Trial in Nanjing (Selective internal radiation therapy (SIRT) with yttrium-90 carbon

Recruiting
  • Unresectable Colorectal Liver Metastases
  • Selective internal radiation therapy (SIRT) with yttrium-90 carbon microspheres
  • Nanjing, Jiangsu, China
    Zhongda Hospital Southeast University
Jan 26, 2023

Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors Trial in Little Rock, Buffalo, Philadelphia (Capecitabine Oral Product,

Recruiting
  • Neuroendocrine Tumor Grade 2
  • Liver Metastases
  • Capecitabine tablets + temozolomide tablets + SIR-Spheres
  • Philadelphia, Pennsylvania
    Abramson Cancer Center
Oct 1, 2021

Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as

Completed
  • Colorectal Cancer Metastatic
  • Targeted agent
  • (no location specified)
Aug 31, 2023

Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors Trial in Little Rock, Buffalo, Philadelphia (Capecitabine Oral Product,

Recruiting
  • Neuroendocrine Tumor Grade 2
  • Neuroendocrine Tumors
  • Capecitabine Oral Product
  • +2 more
  • Little Rock, Arkansas
  • +2 more
Aug 11, 2022

Colorectal Tumors Trial in Hangzhou (Resin microspheres containing yttrium-90 (Y-90))

Not yet recruiting
  • Colorectal Neoplasms
  • Resin microspheres containing yttrium-90 (Y-90)
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang
Oct 11, 2023

Colorectal Cancer Metastatic, Liver Metastasis Colon Cancer Trial (Stereotactic Body Radiotherapy, Microwave Ablation)

Recruiting
  • Colorectal Cancer Metastatic
  • Liver Metastasis Colon Cancer
  • Stereotactic Body Radiotherapy
  • Microwave Ablation
  • Amsterdam, Noord Holland, Netherlands
    Amsterdam UMC
Dec 18, 2022

Liver Cancer Trial in Kansas City (Stereotactic Body Radiation Treatment)

Not yet recruiting
  • Liver Cancer
  • Stereotactic Body Radiation Treatment
  • Kansas City, Kansas
    University of Kansas Medical Center
Feb 13, 2023

Liver Metastasis Trial in Shanghai (Sintilimab, Lenvatinib, Cryoablation)

Recruiting
  • Liver Metastasis
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 8, 2022

HepaSphere Transarterial Chemoembolization Combined With Hepatic

Not yet recruiting
  • Colorectal Liver Metastases (CRCLM)
  • DEB-TACE plus HAIC
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 25, 2023

Child-Pugh Class A, Child-Pugh Class B, Stage IIIA Hepatocellular Carcinoma Trial in Columbus (other, radiation, procedure)

Completed
  • Child-Pugh Class A
  • +6 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Oct 5, 2021

Liver Metastasis Colon Cancer Trial (Living donor liver transplantation)

Recruiting
  • Liver Metastasis Colon Cancer
  • Living donor liver transplantation
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 1, 2022

Unresectable Hepatocellular Carcinoma (HCC), Liver Metastases From Colorectal Cancer (mCRC) Trial in France, Spain, United

Recruiting
  • Unresectable Hepatocellular Carcinoma (HCC)
  • Liver Metastases From Colorectal Cancer (mCRC)
  • SIRT
  • Clichy, Cedex, France
  • +8 more
Jul 31, 2023

Hepatocellular Carcinoma, Cancer of Liver Trial (PXS-5505 and Atezolizumab and Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Cancer of Liver
  • PXS-5505 and Atezolizumab and Bevacizumab
  • Rochester, New York
    University of Rochester
Nov 3, 2022

Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)

Recruiting
  • Colorectal Cancer Metastatic
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 3, 2023

Hepatocellular Carcinoma Non-resectable, Portal Vein Tumor Thrombus, Immune Checkpoint Inhibitors Trial in Nanning (Cadonilimab,

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • +2 more
  • Nanning, Guangxi, China
    First Affiliated Hospital of Guangxi Medical University
Sep 13, 2023

Relapse After Conversion Hepatectomy for Initially Unresectable

Completed
  • Colorectal Cancer
  • Liver Metastases
  • Repeat Liver Surgery
  • Non-Repeat Liver Surgery
  • (no location specified)
Jul 16, 2022

Liver Cancer Trial in Wuhan (Autologous Tumor Infiltrating Lymphocytes)

Recruiting
  • Liver Cancer
  • Autologous Tumor Infiltrating Lymphocytes
  • Wuhan, China
    Tongji Hospital
Oct 9, 2023

Liver Malignant Tumors, Cholangiocarcinoma Metastatic, Pancreatic Cancer Trial in Houston (high dose rate brachytherapy)

Recruiting
  • Liver Malignant Tumors
  • +3 more
  • high dose rate brachytherapy
  • Houston, Texas
    M D Anderson Cancer Center
Apr 25, 2022